Ensuring adequate access for medical and scientific purposes CND Intersessional Vienna Austria 4 September 2014 Stefano Berterame Chief Narcotics Control and Estimates Section Secretariat ID: 736295
Download Presentation The PPT/PDF document "Availability of internationally controll..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Availability of internationally controlled drugs: Ensuring adequate access for medical and scientific purposesCND IntersessionalVienna, Austria4 September 2014Stefano Berterame, ChiefNarcotics Control and Estimates SectionSecretariat of the International Narcotics Control Board Slide2
Unnecessary pain and suffering for many people5.5 million terminal cancer patients 1 million end-stage HIV/AIDS patients;0.8 million patients suffering injuries caused by accidents and violence;Women in labour (110 million births each year)Patients with chronic illnesses; recovering from surgery; WHO estimates that the number of people affected “are the same in magnitude as those afflicted by conditions that are recognized as major contributors to the world’s burden of disease; in particular HIV, malaria and tuberculosis “Slide3
Main goals of the ConventionsSlide4
Availability for medical purposes 1961 ConventionPreambular paragraph: “recognizing that the medical use of narcotic drugs continues to be indispensable for the relief of pain and suffering”.Article 9, paragraph 4, 1961 Convention, as amended by the 1972 Protocol . INCB mandate: “ensuring their availability for such purposes”.1971 Convention: Use of psychotropic substances is indispensable.Availability for such purposes should not be unduly restricted.Slide5
Preventing diversion and abuse1961 ConventionPreambular paragraph: “Recognizing that addiction to narcotic drugs constitutes a serious evil for the individual and is fraught with social and economic danger to manking”.1971 Convention: Preambular paragraph “Noting with concent the public health and social problems resulting from the abuse of certain psychotropic substances” … “Considerng that rigorous measures are necessary to restrict the use of such substances to legitimate purposes”Slide6
Obstacles to availabilitySlide7
TonsStocks of opiate raw materialsfor the extraction of morphineTonsSlide8
Supply (stocks + production) ofand demand for opiate raw materials expressed in morphine equivalentSlide9
TonsStocks of opiate raw materialsfor the extraction of thebaineTonsSlide10
Supply (stocks + production) of and demand for opiate raw materials expressed in thebaine equivalentSlide11
Availability of opioids for pain management2000-2002 avg – 2010-2012 avgSlide12
Availability of opioids for pain management2010-2012 avgSlide13
Average consumption of benzodiazepines (anxiolytics)1997-1999 and 2007-2009 Slide14
Average consumption of central nervous systemstimulants in Schedule IV, 1997-1999 and 2007-2009 Slide15
Recommendations contained in the 2010 report on AvailabilitySlide16
Availability of Narcotic Drugs and Psychotropic substancesCorrect assessment of the needs;Geographical distribution of the drugs;Affordability (coverage by the health system) Identification of obstacles in various areas (legislation, undue restrictions, etc.);Information and monitoring.Slide17
Appropriate useTraining and education of health professionals;Appropriate prescription practices;Education of the public on safe use;Registration system to prevent (doctors shopping, over prescription, etc.);Encourage the use of better and safer therapeutic agents.Slide18
National control systemControl and supervision of supply and consumption of internationally controlled drugs;Improve regulatory system on manufacture, export, import and distribution;Combat counterfeit drugs;Slide19
Prevention of diversion and abuseMeasures against illicit manufacture and diversion narcotic drugs and psychotropic substances;Improvement of information systems and data collection;Increase regional and inter-regional cooperation.Slide20
New Report on Availability in 2016At its 108th session, in November 2013 the Board decided to prepare a special report to be published in 2016 as a supplement to INCB annual report for 2015.Focus on the implementation by Governments recommendations contained in the report published in 2010.Slide21
THANK YOU FOR YOUR ATTENTION !INCB Secretariat